clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Pseudomyxoma Peritonei D011553 1 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Prurigo D011536 4 associated lipids
Proteinuria D011507 30 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Pleuropneumonia D011001 3 associated lipids
Pleural Diseases D010995 4 associated lipids
Periodontitis D010518 22 associated lipids
Periodontal Pocket D010514 9 associated lipids
Periodontal Abscess D010508 2 associated lipids
Peptic Ulcer Perforation D010439 3 associated lipids
Peptic Ulcer Hemorrhage D010438 4 associated lipids
Peptic Ulcer D010437 19 associated lipids
Parotitis D010309 4 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Parotid Diseases D010305 1 associated lipids
Paronychia D010304 3 associated lipids
Parkinson Disease D010300 53 associated lipids
Pancreatitis D010195 10 associated lipids
Pain D010146 64 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Otitis Media D010033 12 associated lipids
Osteomyelitis D010019 10 associated lipids
Psittacosis D009956 4 associated lipids
Endophthalmitis D009877 12 associated lipids
Nocardia Infections D009617 6 associated lipids
Neuromuscular Diseases D009468 10 associated lipids
Nasal Polyps D009298 26 associated lipids
Myxoma D009232 1 associated lipids
Myocardial Infarction D009203 21 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Monoclonal Gammopathy of Undetermined Significance D008998 2 associated lipids
Metaplasia D008679 7 associated lipids
Mastoiditis D008417 2 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Mycetoma D008271 4 associated lipids
Lymphangitis D008205 4 associated lipids
Lymphadenitis D008199 8 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Diseases D008171 37 associated lipids
Leprosy D007918 8 associated lipids
Leishmaniasis, Visceral D007898 13 associated lipids
Legionnaires' Disease D007877 4 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Klebsiella Infections D007710 7 associated lipids
Keratoconjunctivitis D007637 3 associated lipids
Ischemia D007511 18 associated lipids
Iritis D007500 2 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Sung JJ et al. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study. 1999 Aliment. Pharmacol. Ther. pmid:10468684
Catalano F et al. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy. 1999 Helicobacter pmid:10469192
Kamada T et al. Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin. 1999 Helicobacter pmid:10469195
Bui KQ et al. Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. 1999 Antimicrob. Agents Chemother. pmid:10471584
Tanaka E et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. 1999 Am. J. Respir. Crit. Care Med. pmid:10471610
Mikamo H et al. Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis. 1999 Sep-Oct Chemotherapy pmid:10473928
Geiderman JM Central nervous system disturbances following clarithromycin ingestion. 1999 Clin. Infect. Dis. pmid:10476775
Gómez Cubillos C et al. [Can macrolide treatment delay the diagnosis of tuberculosis?]. 1999 An Med Interna pmid:10481348
Sato K et al. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines]. 1999 Kekkaku pmid:10481412
Gidoh M [The control leprous peripheral neuropathy and chemotherapy]. 1999 Nihon Hansenbyo Gakkai Zasshi pmid:10481449
Klapper SR and Patrinely JR Periocular atypical mycobacterial infections. 1999 Ophthalmology pmid:10485521
Matsuoka M et al. Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure. 1999 Gut pmid:10486356
Tyagi AK et al. An unreported side effect of topical clarithromycin when used successfully to treat Mycobacterium avium-intracellulare keratitis. 1999 Cornea pmid:10487437
Rodríguez Téllez M et al. Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection. 1999 Rev Esp Enferm Dig pmid:10491487
Gutiérrez-Cabano CA and Raynald AC Gastroprotective effect of intragastric clarithromycin against damage induced by ethanol in rats. 1999 Dig. Dis. Sci. pmid:10492159
Moore PA Dental therapeutic indications for the newer long-acting macrolide antibiotics. 1999 J Am Dent Assoc pmid:10492541
Osato MS et al. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. 1999 Int. J. Antimicrob. Agents pmid:10493611
Hirsh DC and Jang SS Antimicrobial susceptibility of Nocardia nova isolated from five cats with nocardiosis. 1999 J. Am. Vet. Med. Assoc. pmid:10496134
Ellenrieder V et al. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. 1999 Scand. J. Gastroenterol. pmid:10499474
Zgoulli S et al. Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. 1999 Sep-Oct J Microencapsul pmid:10499837